Rethinking placebo-controlled clinical trials in psychedelic therapies for psychiatric illness.
The British Journal of Psychiatry July 21, 2025 Amy Lehrner, Thomas B Hildebrandt, Rachel Yehuda
An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
DOI: 10.1192/bjp.2025.51 (opens in new tab)
Methodology
Placebo
Psychotherapy
Randomised clinical trial
+1